Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02616783
Brief Title: Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years

First Submitted : November 23, 2015
First Submitted that Met QC Criteria : November 27, 2015
First Posted : November 30, 2015 (Estimate)

Results First Submitted : January 31, 2019
Results First Submitted that Met QC Criteria : January 31, 2019
Results First Posted : February 19, 2019

Last Update Submitted that Met QC Criteria : February 18, 2020
Last Update Posted : March 4, 2020